Global Antibiotic Resistance Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Antibiotic Resistance Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.
Antibiotic Resistance report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antibiotic Resistance market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oxazolidinones and Lipoglycopeptides are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antibiotic Resistance industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antibiotic Resistance key manufacturers include Allergan, AmpliPhi Biosciences, BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience and Phage Technologies S.A, etc. Allergan, AmpliPhi Biosciences, BioVersys GmbH are top 3 players and held % sales share in total in 2022.
Antibiotic Resistance can be divided into , etc. is the mainstream product in the market, accounting for % sales share globally in 2022.
Antibiotic Resistance is widely used in various fields, such as Oxazolidinones, Lipoglycopeptides, Tetracyclines and Cephalosporins, etc. Oxazolidinones provides greatest supports to the Antibiotic Resistance industry development. In 2022, global % sales of Antibiotic Resistance went into Oxazolidinones filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antibiotic Resistance market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Allergan
AmpliPhi Biosciences
BioVersys GmbH
Macrolide Pharmaceuticals
Melinta Therapeutics
Merck
Nabriva Therapeutics
Nemesis Bioscience
Phage Technologies S.A
Tetraphase Pharmaceuticals
The Medicines Company
TPfizer
Westway Health
Segment by Type
By Disease
By Pathogen
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antibiotic Resistance market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antibiotic Resistance, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antibiotic Resistance industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antibiotic Resistance in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antibiotic Resistance introduction, etc. Antibiotic Resistance Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antibiotic Resistance market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Antibiotic Resistance report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antibiotic Resistance market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Oxazolidinones and Lipoglycopeptides are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antibiotic Resistance industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antibiotic Resistance key manufacturers include Allergan, AmpliPhi Biosciences, BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience and Phage Technologies S.A, etc. Allergan, AmpliPhi Biosciences, BioVersys GmbH are top 3 players and held % sales share in total in 2022.
Antibiotic Resistance can be divided into , etc. is the mainstream product in the market, accounting for % sales share globally in 2022.
Antibiotic Resistance is widely used in various fields, such as Oxazolidinones, Lipoglycopeptides, Tetracyclines and Cephalosporins, etc. Oxazolidinones provides greatest supports to the Antibiotic Resistance industry development. In 2022, global % sales of Antibiotic Resistance went into Oxazolidinones filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antibiotic Resistance market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Allergan
AmpliPhi Biosciences
BioVersys GmbH
Macrolide Pharmaceuticals
Melinta Therapeutics
Merck
Nabriva Therapeutics
Nemesis Bioscience
Phage Technologies S.A
Tetraphase Pharmaceuticals
The Medicines Company
TPfizer
Westway Health
Segment by Type
By Disease
By Pathogen
Segment by Application
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antibiotic Resistance market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antibiotic Resistance, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antibiotic Resistance industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antibiotic Resistance in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antibiotic Resistance introduction, etc. Antibiotic Resistance Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Antibiotic Resistance market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices